Cite

HARVARD Citation

    Lazaridou, M. et al. (2020). Identification of miR-200a-5p targeting the peptide transporter TAP1 and its association with the clinical outcome of melanoma patients. Oncoimmunology. p. . [Online]. 
  
Back to record